Rhapsido

Active Ingredient(s): Remibrutinib
FDA Approved: * September 30, 2025
Pharm Company: * NOVARTIS PHARMS CORP
Category: Skin Care
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Rhapsido 25 mg Oral Tablet
NDC: 0078-1483
Labeler:
Novartis Pharmaceuticals Corporation